The IL-4 receptor: signaling mechanisms and biologic functions.

Interleukin-4 is a multifunctional cytokine that plays a critical role in the regulation of immune responses. Its effects depend upon binding to and signaling through a receptor complex consisting of the IL-4R alpha chain and the common gamma chain (gamma c), resulting in a series of phosphorylation events mediated by receptor-associated kinases. In turn, these cause the recruitment of mediators of cell growth, of resistance to apoptosis, and of gene activation and differentiation. Here we describe our current understanding of the organization of the IL-4 receptor, of the signaling pathways that are induced as a result of receptor occupancy, and of the various mechanisms through which receptor function is modulated. We particularly emphasize the modular nature of the receptor and the specialization of different receptor regions for distinct functions, most notably the independent regulation of cell growth and gene activation.

[1]  W. Sebald,et al.  The interleukin‐4 site‐2 epitope determining binding of the common receptor γ chain , 1998 .

[2]  W. Paul,et al.  Characterization of a mobile Stat6 activation motif in the human IL-4 receptor. , 1998, Journal of immunology.

[3]  J. Zamorano,et al.  Regulation of apoptosis by tyrosine-containing domains of IL-4R alpha: Y497 and Y713, but not the STAT6-docking tyrosines, signal protection from apoptosis. , 1998, Journal of immunology.

[4]  W. Paul,et al.  FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation. , 1998, Immunity.

[5]  J. Stavnezer,et al.  Interaction of Stat6 and NF-κB: Direct Association and Synergistic Activation of Interleukin-4-Induced Transcription , 1998, Molecular and Cellular Biology.

[6]  P. Pereira,et al.  Requirement for γδ T Cells in Allergic Airway Inflammation , 1998 .

[7]  R. Puri,et al.  Interleukin-13 Receptor α′ But Not α Chain: A Functional Component of Interleukin-4 Receptors , 1998 .

[8]  M. Gadina,et al.  Involvement of SHP-2 in multiple aspects of IL-2 signaling: evidence for a positive regulatory role. , 1998, Journal of immunology.

[9]  W. Paul,et al.  Impaired Interleukin 4 Signaling in T Helper Type 1 Cells , 1998, The Journal of experimental medicine.

[10]  J. Zamorano,et al.  A Role for the Insulin-Interleukin (IL)-4 Receptor Motif of the IL-4 Receptor α-Chain in Regulating Activation of the Insulin Receptor Substrate 2 and Signal Transducer and Activator of Transcription 6 Pathways , 1998, The Journal of Biological Chemistry.

[11]  M. Kaplan,et al.  Stat Proteins Control Lymphocyte Proliferation by Regulating p27Kip1 Expression , 1998, Molecular and Cellular Biology.

[12]  P. Marrack,et al.  Cytokine-induced survival of activated T cells in vitro and in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Shoelson,et al.  Crystal Structure of the Tyrosine Phosphatase SHP-2 , 1998, Cell.

[14]  F. Finkelman,et al.  IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. , 1998, Immunity.

[15]  P. Pandolfi,et al.  Molecular Cloning and Characterization of p56 dok-2 Defines a New Family of RasGAP-binding Proteins* , 1998, The Journal of Biological Chemistry.

[16]  J. Pierce,et al.  Regulation of interleukin 4-mediated signaling by naturally occurring dominant negative and attenuated forms of human Stat6. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Y. Yazaki,et al.  c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3'-kinase pathway. , 1998, Blood.

[18]  N. Hamasaki,et al.  Ile50Val variant of IL4Rα upregulates IgE synthesis and associates with atopic asthma , 1998, Nature Genetics.

[19]  T. Chatila,et al.  The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. , 1997, The New England journal of medicine.

[20]  L. Steinman,et al.  CD4+ T-cell subsets in autoimmunity. , 1997, Current opinion in immunology.

[21]  D. Leroith,et al.  A Molecular Basis for Insulin Resistance , 1997, The Journal of Biological Chemistry.

[22]  M. Boothby,et al.  HMG-I(Y) Phosphorylation Status as a Nuclear Target Regulated through Insulin Receptor Substrate-1 and the I4R Motif of the Interleukin-4 Receptor* , 1997, The Journal of Biological Chemistry.

[23]  G. Freeman,et al.  Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. , 1997, Science.

[24]  W. Paul,et al.  An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  I. Kerr,et al.  Janus Kinase-dependent Activation of Insulin Receptor Substrate 1 in Response to Interleukin-4, Oncostatin M, and the Interferons* , 1997, The Journal of Biological Chemistry.

[26]  J. Darnell STATs and gene regulation. , 1997, Science.

[27]  W. Paul,et al.  Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. , 1997, Journal of immunology.

[28]  G. Lienhard,et al.  A Novel 160-kDa Phosphotyrosine Protein in Insulin-treated Embryonic Kidney Cells Is a New Member of the Insulin Receptor Substrate Family* , 1997, The Journal of Biological Chemistry.

[29]  G. Stark,et al.  Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Dantzer,et al.  IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors. , 1997, Journal of immunology.

[31]  S. Akira,et al.  Structure and function of a new STAT-induced STAT inhibitor , 1997, Nature.

[32]  Takaho A. Endo,et al.  A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.

[33]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[34]  B. Nelson,et al.  The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression. , 1997, Journal of immunology.

[35]  A. Toker,et al.  Signalling through the lipid products of phosphoinositide-3-OH kinase , 1997, Nature.

[36]  H. Fujiwara,et al.  Homodimerization of the human interleukin 4 receptor alpha chain induces Cepsilon germline transcripts in B cells in the absence of the interleukin 2 receptor gamma chain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Manning,et al.  Interleukin-4 Suppression of Tumor Necrosis Factor α-stimulated E-selectin Gene Transcription Is Mediated by STAT6 Antagonism of NF-κB* , 1997, The Journal of Biological Chemistry.

[38]  B. Brown,et al.  A 70-kDa protein facilitates interleukin-4 signal transduction in the absence of the common gamma receptor chain. , 1997, Biochemical and biophysical research communications.

[39]  B. Čatipović,et al.  Interleukin-4 (IL-4) Induces Phosphatidylinositol 3-Kinase (p85) Dephosphorylation , 1997, The Journal of Biological Chemistry.

[40]  R. Flavell,et al.  Jak1 Expression Is Required for Mediating Interleukin-4-induced Tyrosine Phosphorylation of Insulin Receptor Substrate and Stat6 Signaling Molecules* , 1997, The Journal of Biological Chemistry.

[41]  Lewis C Cantley,et al.  PI3K: Downstream AKTion Blocks Apoptosis , 1997, Cell.

[42]  W. Paul,et al.  The IL-4-induced tyrosine phosphorylation of the insulin receptor substrate is dependent on JAK1 expression in human fibrosarcoma cells. , 1997, Journal of immunology.

[43]  N. Copeland,et al.  The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action. , 1997, Molecular endocrinology.

[44]  David R. Kaplan,et al.  Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate , 1997, Science.

[45]  D. Baltimore,et al.  Identification of the Abl- and rasGAP-Associated 62 kDa Protein as a Docking Protein, Dok , 1997, Cell.

[46]  R. Kobayashi,et al.  p62 dok : A Constitutively Tyrosine-Phosphorylated, GAP-Associated Protein in Chronic Myelogenous Leukemia Progenitor Cells , 1997, Cell.

[47]  P. Ferrara,et al.  Cloning of the human IL‐13Rα1 chain and reconstitution with the IL‐4Rα of a functional IL‐4/IL‐13 receptor complex , 1997 .

[48]  R. Puri,et al.  The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. , 1997, Journal of immunology.

[49]  S. Akira,et al.  NF-IL6 and NF-kappa B in cytokine gene regulation. , 1997, Advances in immunology.

[50]  J. Kinet,et al.  The Emerging Field of Receptor-Mediated Inhibitory Signaling: SHP or SHIP? , 1996, Cell.

[51]  J. Cambier,et al.  The SHIP phosphatase becomes associated with Fc gammaRIIB1 and is tyrosine phosphorylated during 'negative' signaling. , 1996, Immunology letters.

[52]  Ling-mei Wang,et al.  IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. , 1996, Journal of immunology.

[53]  R. Puri,et al.  cDNA Cloning and Characterization of the Human Interleukin 13 Receptor α Chain* , 1996, The Journal of Biological Chemistry.

[54]  K. Izuhara,et al.  Interleukin-4 induces association of the c-fes proto-oncogene product with phosphatidylinositol-3 kinase. , 1996, Blood.

[55]  G. Krystal,et al.  Cloning and characterization of human SHIP, the 145-kD inositol 5-phosphatase that associates with SHC after cytokine stimulation. , 1996, Blood.

[56]  U. Schindler,et al.  Requirements for interleukin-4-induced gene expression and functional characterization of Stat6 , 1996, Molecular and cellular biology.

[57]  B. Groner,et al.  Homodimerization of Interleukin-4 Receptor α Chain Can Induce Intracellular Signaling* , 1996, The Journal of Biological Chemistry.

[58]  H. Band,et al.  A Novel Phosphotyrosine-binding Domain in the N-terminal Transforming Region of Cbl Interacts Directly and Selectively with ZAP-70 in T Cells* , 1996, The Journal of Biological Chemistry.

[59]  D T Denhardt,et al.  Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. , 1996, The Biochemical journal.

[60]  M. Goldsmith,et al.  Interleukin‐4‐specific signal transduction events are driven by homotypic interactions of the interleukin‐4 receptor alpha subunit. , 1996, The EMBO journal.

[61]  Enrico A. Stura,et al.  Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å , 1996, Science.

[62]  V. Band,et al.  Tyrosine Phosphorylation of Cbl upon Epidermal Growth Factor (EGF) Stimulation and Its Association with EGF Receptor and Downstream Signaling Proteins* , 1996, The Journal of Biological Chemistry.

[63]  S. Shoelson,et al.  Structure of the IRS-1 PTB Domain Bound to the Juxtamembrane Region of the Insulin Receptor , 1996, Cell.

[64]  W. Paul,et al.  Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene , 1996, Nature.

[65]  S. Akira,et al.  Essential role of Stat6 in IL-4 signalling , 1996, Nature.

[66]  R. Puri,et al.  IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling. , 1996, Journal of immunology.

[67]  J. Bertoglio,et al.  Interleukin-4 Induces Activation of Mitogen-activated Protein Kinase and Phosphorylation of Shc in Human Keratinocytes (*) , 1996, The Journal of Biological Chemistry.

[68]  R. Meadows,et al.  Structural basis for IL-4 receptor phosphopeptide recognition by thelRS-1 PTB domain , 1996, Nature Structural Biology.

[69]  M. Kaplan,et al.  Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. , 1996, Immunity.

[70]  P. Majerus,et al.  The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[71]  S. Shoelson,et al.  p120 Is a Major Substrate of Tyrosine Phosphorylation upon B Cell Antigen Receptor Stimulation and Interacts in Vivo with Fyn and Syk Tyrosine Kinases, Grb2 and Shc Adaptors, and the p85 Subunit of Phosphatidylinositol 3-Kinase (*) , 1996, The Journal of Biological Chemistry.

[72]  J. Ihle STATs: Signal Transducers and Activators of Transcription , 1996, Cell.

[73]  W. Paul,et al.  IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain. , 1996, Immunity.

[74]  W. Paul,et al.  Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. , 1996, Immunity.

[75]  A. DeFranco,et al.  Activation-induced Association of a 145-kDa Tyrosine-phosphorylated Protein with Shc and Syk in B Lymphocytes and Macrophages (*) , 1996, The Journal of Biological Chemistry.

[76]  J. G. Zhang,et al.  Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Eric O Long,et al.  Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. , 1996, Immunity.

[78]  C. Marshall,et al.  Control of the ERK MAP kinase cascade by Ras and Raf. , 1996, Cancer surveys.

[79]  J. Downward,et al.  Control of ras activation. , 1996, Cancer surveys.

[80]  Dwight C. Look,et al.  Stat1 Depends on Transcriptional Synergy with Sp1 (*) , 1995, The Journal of Biological Chemistry.

[81]  A. Petros,et al.  Structure and ligand recognition of the phosphotyrosine binding domain of Shc , 1995, Nature.

[82]  J. Johnston,et al.  Interleukins 2, 4, 7, and 15 Stimulate Tyrosine Phosphorylation of Insulin Receptor Substrates 1 and 2 in T Cells POTENTIAL ROLE OF JAK KINASES (*) , 1995, The Journal of Biological Chemistry.

[83]  Roger J. Davis,et al.  Transcriptional regulation by MAP kinases , 1995, Molecular reproduction and development.

[84]  S Goelz,et al.  Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1 , 1995, Molecular and cellular biology.

[85]  M. White,et al.  PTB Domains of IRS-1 and Shc Have Distinct but Overlapping Binding Specificities (*) , 1995, The Journal of Biological Chemistry.

[86]  P. Sigler,et al.  Specific and high-affinity binding of inositol phosphates to an isolated pleckstrin homology domain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[87]  W. Fridman,et al.  The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. , 1995, Immunity.

[88]  L. Sanders,et al.  Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[89]  E. Petricoin,et al.  Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. , 1995, Science.

[90]  William Arbuthnot Sir Lane,et al.  Role of IRS-2 in insulin and cytokine signalling , 1995, Nature.

[91]  G. Lienhard,et al.  Interleukin-9 Induces Tyrosine Phosphorylation of Insulin Receptor Substrate-1 via JAK Tyrosine Kinases (*) , 1995, The Journal of Biological Chemistry.

[92]  J. Stavnezer,et al.  Regulation of Antibody Class Switching to IgE: Characterization of an IL‐4‐Responsive Region in the Immunoglobulin Heavy‐Chain Germline ε Promoter a , 1995, Annals of the New York Academy of Sciences.

[93]  S. Shoelson,et al.  The SH3 Domain-binding T Cell Tyrosyl Phosphoprotein p120 , 1995, The Journal of Biological Chemistry.

[94]  S. Shoelson,et al.  Specificity of the PTB Domain of Shc for β Turn-forming Pentapeptide Motifs Amino-terminal to Phosphotyrosine (*) , 1995, The Journal of Biological Chemistry.

[95]  J. Darnell,et al.  Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation , 1995, Cell.

[96]  I. Pastan,et al.  A Novel Chimeric Protein Composed of Interleukin 13 and Pseudomonas Exotoxin Is Highly Cytotoxic to Human Carcinoma Cells Expressing Receptors for Interleukin 13 and Interleukin 4 (*) , 1995, The Journal of Biological Chemistry.

[97]  C. Thompson,et al.  Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[98]  S. McKnight,et al.  Components of a Stat recognition code: evidence for two layers of molecular selectivity. , 1995, Immunity.

[99]  M. Welham,et al.  Interleukin-13 Signal Transduction in Lymphohemopoietic Cells , 1995, The Journal of Biological Chemistry.

[100]  A. Craparo,et al.  Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain , 1995, Molecular and cellular biology.

[101]  J. Chung,et al.  Distinct sequence motifs within the cytoplasmic domain of the human IL-4 receptor differentially regulate apoptosis inhibition and cell growth. , 1995, Journal of Immunology.

[102]  T. Taniguchi Cytokine signaling through nonreceptor protein tyrosine kinases. , 1995, Science.

[103]  K. Siminovitch,et al.  Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. , 1995, Science.

[104]  R. Puri,et al.  Receptor for Interleukin 13 , 1995, The Journal of Biological Chemistry.

[105]  T. Blankenstein,et al.  The rat interleukin 4 receptor: coevolution of ligand and receptor. , 1995, Cytokine.

[106]  J. Blenis,et al.  Requirement of serine phosphorylation for formation of STAT-promoter complexes. , 1995, Science.

[107]  E. Skolnik,et al.  Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin , 1995, Molecular and cellular biology.

[108]  R. Reeves,et al.  The non‐histone chromosomal protein HMG‐I(Y) contributes to repression of the immunoglobulin heavy chain germ‐line ε RNA promoter , 1995, European journal of immunology.

[109]  Tony Pawson,et al.  Protein modules and signalling networks , 1995, Nature.

[110]  T. Pawson Getting down to specifics , 1995, Nature.

[111]  M. Schrenzel,et al.  Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo , 1995, Nature.

[112]  A. Duschl,et al.  Both Interleukin 4 and Interleukin 13 Induce Tyrosine Phosphorylation of the 140-kDa Subunit of the Interleukin 4 Receptor (*) , 1995, The Journal of Biological Chemistry.

[113]  J. Stavnezer,et al.  Characterization of an interleukin 4 (IL-4) responsive region in the immunoglobulin heavy chain germline epsilon promoter: regulation by NF- IL-4, a C/EBP family member and NF-kappa B/p50 , 1995, The Journal of experimental medicine.

[114]  J. Ihle The Janus protein tyrosine kinase family and its role in cytokine signaling. , 1995, Advances in immunology.

[115]  L. Williams,et al.  An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. , 1994, Science.

[116]  O. Silvennoinen,et al.  Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. , 1994, Science.

[117]  J. Johnston,et al.  Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. , 1994, Science.

[118]  T. O’Neill,et al.  Characterization of an interaction between insulin receptor substrate 1 and the insulin receptor by using the two-hybrid system , 1994, Molecular and cellular biology.

[119]  T Pawson,et al.  Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. , 1994, Oncogene.

[120]  S. McKnight,et al.  An interleukin-4-induced transcription factor: IL-4 Stat. , 1994, Science.

[121]  D. Bowtell,et al.  Multiple hemopoietins, with the exception of interleukin-4, induce modification of Shc and mSos1, but not their translocation. , 1994, The Journal of biological chemistry.

[122]  N. Ruderman,et al.  The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by Wortmannin. , 1994, The Journal of biological chemistry.

[123]  L. Cantley,et al.  Phosphatidylinositol 3‐kinase , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[124]  K. Izuhara,et al.  Interaction of the c-fes proto-oncogene product with the interleukin-4 receptor. , 1994, The Journal of biological chemistry.

[125]  E. Liu,et al.  Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells , 1994, Nature.

[126]  J. Johnston,et al.  Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2 , 1994, Nature.

[127]  M. Nussenzweig,et al.  A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling , 1994, Nature.

[128]  W. Paul,et al.  CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3 , 1994, The Journal of experimental medicine.

[129]  P. Leder,et al.  Mutational analysis of a critical signaling domain of the human interleukin 4 receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[130]  W. Paul,et al.  An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth , 1994, Cell.

[131]  M. Nussenzweig,et al.  A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling , 1994, Nature.

[132]  V. Duronio,et al.  Interleukin-4-dependent proliferation dissociates p44erk-1, p42erk-2, and p21ras activation from cell growth. , 1994, The Journal of biological chemistry.

[133]  I Gout,et al.  PI 3‐kinase is a dual specificity enzyme: autoregulation by an intrinsic protein‐serine kinase activity. , 1994, The EMBO journal.

[134]  J. Tavernier,et al.  Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion , 1994, The Journal of experimental medicine.

[135]  M. Kasuga,et al.  PI 3‐kinase: structural and functional analysis of intersubunit interactions. , 1994, The EMBO journal.

[136]  L. Cantley,et al.  Identification of two SH3-binding motifs in the regulatory subunit of phosphatidylinositol 3-kinase. , 1994, The Journal of biological chemistry.

[137]  W. Paul,et al.  Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, Annual review of immunology.

[138]  W. Leonard,et al.  Sharing of a common gamma chain, gamma c, by the IL-2, IL-4, and IL-7 receptors: implications for X-linked severe combined immunodeficiency (XSCID). , 1994, Advances in experimental medicine and biology.

[139]  S. Ziegler,et al.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. , 1993, Science.

[140]  K. Arai,et al.  Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. , 1993, Science.

[141]  Mark S. Boguski,et al.  Proteins regulating Ras and its relatives , 1993, Nature.

[142]  M. White,et al.  Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1 , 1993, Molecular and cellular biology.

[143]  G. Stark,et al.  Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon‐alpha and ‐gamma signal transduction pathways. , 1993, The EMBO journal.

[144]  P. Hawkins,et al.  Agonist-stimulated synthesis of phosphatidylinositol(3,4,5)-trisphosphate: a new intracellular signalling system? , 1993, Biochimica et biophysica acta.

[145]  M. White,et al.  IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. , 1993, Science.

[146]  R. Ashman,et al.  Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. , 1993, Journal of immunology.

[147]  A. Klippel,et al.  A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo. , 1993, Molecular and cellular biology.

[148]  D. Beier,et al.  Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene , 1993, Cell.

[149]  T. Pawson,et al.  The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. , 1993, The Journal of biological chemistry.

[150]  M. Wigler,et al.  Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. , 1993, Science.

[151]  G. Lienhard,et al.  Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[152]  F. Kalthoff,et al.  Human interleukin‐4 receptor signaling requires sequences contained within two cytoplasmic regions , 1993, European journal of immunology.

[153]  T. Pawson,et al.  SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.

[154]  R. Perlmutter,et al.  Association of p56lck with IL‐2 receptor beta chain is critical for the IL‐2‐induced activation of p56lck. , 1993, The EMBO journal.

[155]  Sheila M. Thomas,et al.  Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases , 1992, Nature.

[156]  J. Gutkind,et al.  IL‐4 activates a distinct signal transduction cascade from IL‐3 in factor‐dependent myeloid cells. , 1992, The EMBO journal.

[157]  G. Delespesse,et al.  Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression , 1992, The Journal of experimental medicine.

[158]  W. Paul,et al.  The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice , 1992, The Journal of experimental medicine.

[159]  M. Fellous,et al.  A protein tyrosine kinase in the interferon α β signaling pathway , 1992, Cell.

[160]  C. Hsieh,et al.  Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[161]  V. Duronio,et al.  p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[162]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[163]  K. Yasukawa,et al.  Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[164]  K. Clauser,et al.  Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. , 1991, Science.

[165]  K. Rajewsky,et al.  Generation and analysis of interleukin-4 deficient mice. , 1991, Science.

[166]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[167]  H. Gascan,et al.  Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones , 1991, The Journal of experimental medicine.

[168]  J. Lanchbury,et al.  Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. , 1991, Journal of immunology.

[169]  J. Banchereau,et al.  Molecular cloning of a cDNA encoding the human interleukin 4 receptor. , 1990, International immunology.

[170]  Alan I. Alpert,et al.  The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms , 1989, Cell.

[171]  P. Libby,et al.  PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells , 1989, Cell.

[172]  W. Paul,et al.  Up-regulation of interleukin 4/B-cell stimulatory factor 1 receptor expression. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[173]  A. Ullrich,et al.  Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity , 1988, Cell.

[174]  W. Paul,et al.  Interleukin 4 induces membrane Thy-1 expression on normal murine B cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[175]  J. Lowenthal,et al.  Expression of high affinity receptors for murine interleukin 4 (BSF-1) on hemopoietic and nonhemopoietic cells. , 1988, Journal of immunology.

[176]  F. McCormick,et al.  A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. , 1987, Science.

[177]  K. Arai,et al.  Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes , 1987, The Journal of experimental medicine.

[178]  W. Paul,et al.  Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage , 1987, Nature.

[179]  E. Shevach,et al.  B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes , 1987, The Journal of experimental medicine.

[180]  R. Coffman,et al.  B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. , 1986, Journal of immunology.

[181]  W. Paul,et al.  Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1 , 1985, The Journal of experimental medicine.

[182]  J. Uhr,et al.  Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[183]  W. Paul,et al.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2 , 1982, The Journal of experimental medicine.

[184]  R. Huebner,et al.  Genetic control by the hr-locus of susceptibility and resistance to leukemia. , 1969, Proceedings of the National Academy of Sciences of the United States of America.